PROPHYLAXIS OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ACTIVE ONCOLOGICAL DISEASE, RECEIVING MEDICAL ANTI-CANCER CHEMOTHERAPY IN OUTPATIENT CONDITIONS. ROLE OF APIXABAN

Oncological disease is one of the most important risk factors for venous thromboembolic complications (VTEC). The treatment of an already confirmed VTEC in an oncological patient is always associated with additional difficulties, which are related to drug interactions, which may affect the efficacy...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yu. A. Fedotkina, E. P. Panchenko
Format:	Artigo
Idioma:	Russo
Publicat:	«REMEDIUM GROUP» Ltd. 2020-01-01
Col·lecció:	Атеротромбоз
Matèries:	cancer-associated venous thrombosis drug prophylaxis of venous thrombosis in cancer patients receiving chemotherapy low-molecular weight heparins direct oral anticoagulants apixaban
Accés en línia:	https://www.aterotromboz.ru/jour/article/view/198
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!